Setting new standards for hyaluronic acid

Novozymes Biopolymer develops, produces, and sells hyaluronic acid (HA)  to forward-thinking partners within the medical device and pharmaceutical industries. All our products are certified to ISO 9000:2001.

In partnership with our customers, we rethink established processes and products to find better ways to solve age-old problems. In other words, we provide sustainable answers through bioinnovation.

Safe, pure, practical hyaluronic acid
Hyaluronic acid (HA) is a polysaccharide that occurs naturally in the body. It features exceptional water-binding capacity and remarkable visco-elastic properties, which makes it ideal for a wide range of applications, including:

• Eye care
• Wound care
• Cosmetics
• Dermatology
• Injectables 
• Pharmaceuticals

World’s first endotoxin-free host strain for HA
Our flagship product is HyaCare®, the world’s first HA produced without the use of animal-derived raw materials and organic solvents. And to meet the growing need for pharmaceutical-grade HA, we are currently building a state-of-the-art cGMP HyaCare facility. It will offer a full Q7A cGMP-validated process.

Unsurpassed R&D resources
As part of the Novozymes Group, one of the world’s largest and most respected suppliers of specialized enzymes, we have access to unsurpassed resources when it comes to R&D. We are tapped into a global network that lets us create the uncommon connections that make innovation possible. We help our customers prepare for tomorrow’s demands by providing unrivaled technical expertise to create genuine product benefits.

Learn more about HyaCare
Find out how you can create new and better products